Table 2.
Summary of key features of oral manifestations in selected diseases.
Disease | Type | Immune Factors | Risk Factors | Symptoms |
---|---|---|---|---|
MMP | Autoimmune dermatoses disease | Linear deposition of IgG, IgA, C3, rarely IgG Target antigens in the basement membrane region of the epithelium: BP230, BP180, laminin 5, laminin 6, type VII collagen and β4 |
Age > 50 years, female sex | Subepidermal bullous lesions |
PV | Autoimmune disease | Autoantibodies react to Dsg 1 and 3 | - | Ulceration of the oral and esophageal mucosa, followed by skin involvement |
LABD | Subepidermal vesiculobullous disease | Deposition of IgA rather than IgG in the basement membrane | Genetic factors, medication (vancomycin) and antibiotic use (cephalosporins, penicillins) | Oral lesions clinically identical to MMPs |
EBA | Autoimmune blistering disease | IgG autoantibodies directed against type VII collagen | - | Blisters and blisters on the skin and erosions on the mucous membranes |
HIES | Multisystem disorder | - | STAT3 mutations | Facial asymmetry, fleshy nose tip, deep-set eyes, prominent forehead, triad of eczema, recurrent skin and lung infections, high serum IgE levels, preserved primary dentition, oral mucosal and gingival lesions, oral candidiasis |
IgG: immunoglobulin G; IgA: immunoglobulin A; IgE: immunoglobulin E; C3: complement component 3; MMP: mucous membrane pemphigoid; PV: pemphigus vulgaris; LABD: linear IgA bullous dermatosis; EBA: Epidermolysis Bullosa Aquisita; HIES: Hyper-IgE syndrome; STAT3: Signal transducer and activator of transcription 3.